WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018082758) IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/082758 International Application No.: PCT/DK2017/050363
Publication Date: 11.05.2018 International Filing Date: 03.11.2017
IPC:
G01N 33/574 (2006.01) ,G01N 33/566 (2006.01) ,A61K 47/64 (2017.01)
Applicants: AARHUS UNIVERSITET[DK/DK]; Nordre Ringgade 1 8000 Aarhus C, DK
ALBUMEDIX LTD.[GB/GB]; Castle Court 59 Castle Boulevard Nottingham NG7 1FD, GB
Inventors: HOWARD, Kenneth Alan; DK
CAMERON, Jason; GB
LARSEN, Maja Thim; DK
DAGNÆS-HANSEN, Frederik; DK
Agent: PLOUGMANN VINGTOFT A/S; Rued Langgaards Vej 8 2300 Copenhagen S, DK
Priority Data:
PA 2016 7087004.11.2016DK
Title (EN) IDENTIFICATION AND TREATMENT OF TUMORS CHARACTERIZED BY AN OVEREXPRESSION OF THE NEONATAL FC RECEPTOR
(FR) IDENTIFICATION ET TRAITEMENT DE TUMEURS CARACTÉRISÉES PAR UNE SUREXPRESSION DU RÉCEPTEUR FC NÉONATAL
Abstract: front page image
(EN) In a first aspect, the invention relates to the identification of cancer types over- expressing the FcRn receptor. In a second aspect, the invention relates to the treatment of said cancer types.In further aspects,the invention relates to identification of subtypes of inflammatory diseases and treatments thereof.In an additional aspect, the invention relates to in vivo imaging of cancers over- expressing the FcRn receptor.
(FR) Selon un premier aspect, l'invention concerne l'identification de types de cancers surexprimant le récepteur FcRn. Selon un deuxième aspect, l'invention concerne le traitement desdits types de cancers. Selon d'autres aspects, l'invention concerne l'identification de sous-types de maladies inflammatoires et leurs traitements. Selon un aspect supplémentaire, l'invention concerne l'imagerie in vivo de cancers surexprimant le récepteur FcRn.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)